IOMED — Seed · €2M

IOMED uses AI and natural language processing to turn electronic health records into structured data for clinical research. This €2M round was its third capital increase since it was founded in 2017. Existing investors EASO Ventures and Speedinvest joined, and the money will fund expansion across Spanish hospitals and into Germany and the UK. The company later raised a €10M Series A.